CN117946355A - Preparation method and application of asymmetric self-supporting covalent organic framework film - Google Patents
Preparation method and application of asymmetric self-supporting covalent organic framework film Download PDFInfo
- Publication number
- CN117946355A CN117946355A CN202410359809.7A CN202410359809A CN117946355A CN 117946355 A CN117946355 A CN 117946355A CN 202410359809 A CN202410359809 A CN 202410359809A CN 117946355 A CN117946355 A CN 117946355A
- Authority
- CN
- China
- Prior art keywords
- organic framework
- covalent organic
- membrane
- solution
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000013310 covalent-organic framework Substances 0.000 title claims abstract description 90
- 238000002360 preparation method Methods 0.000 title claims description 11
- 239000000178 monomer Substances 0.000 claims abstract description 47
- 239000012074 organic phase Substances 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 33
- 150000001412 amines Chemical class 0.000 claims abstract description 23
- 238000012546 transfer Methods 0.000 claims abstract description 17
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 92
- 239000000243 solution Substances 0.000 claims description 60
- 239000012528 membrane Substances 0.000 claims description 56
- 229920005597 polymer membrane Polymers 0.000 claims description 33
- 150000003839 salts Chemical class 0.000 claims description 30
- 238000000926 separation method Methods 0.000 claims description 28
- 239000002253 acid Substances 0.000 claims description 27
- 125000000129 anionic group Chemical group 0.000 claims description 17
- 239000008346 aqueous phase Substances 0.000 claims description 15
- 230000007935 neutral effect Effects 0.000 claims description 13
- 125000002091 cationic group Chemical group 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 150000001299 aldehydes Chemical class 0.000 claims description 10
- IQFVPQOLBLOTPF-HKXUKFGYSA-L congo red Chemical compound [Na+].[Na+].C1=CC=CC2=C(N)C(/N=N/C3=CC=C(C=C3)C3=CC=C(C=C3)/N=N/C3=C(C4=CC=CC=C4C(=C3)S([O-])(=O)=O)N)=CC(S([O-])(=O)=O)=C21 IQFVPQOLBLOTPF-HKXUKFGYSA-L 0.000 claims description 10
- 229940012189 methyl orange Drugs 0.000 claims description 10
- STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 claims description 10
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 claims description 8
- HEAHMJLHQCESBZ-UHFFFAOYSA-N 2,5-diaminobenzenesulfonic acid Chemical group NC1=CC=C(N)C(S(O)(=O)=O)=C1 HEAHMJLHQCESBZ-UHFFFAOYSA-N 0.000 claims description 7
- SGHZXLIDFTYFHQ-UHFFFAOYSA-L Brilliant Blue Chemical compound [Na+].[Na+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 SGHZXLIDFTYFHQ-UHFFFAOYSA-L 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 239000003344 environmental pollutant Substances 0.000 claims description 7
- 231100000719 pollutant Toxicity 0.000 claims description 7
- -1 4' -biphenyldiamine Chemical compound 0.000 claims description 6
- 229940079593 drug Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- JVMSQRAXNZPDHF-UHFFFAOYSA-N 2,4-diaminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C(N)=C1 JVMSQRAXNZPDHF-UHFFFAOYSA-N 0.000 claims description 5
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 5
- 229940097275 indigo Drugs 0.000 claims description 5
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 5
- CBCKQZAAMUWICA-UHFFFAOYSA-N 1,4-phenylenediamine Chemical compound NC1=CC=C(N)C=C1 CBCKQZAAMUWICA-UHFFFAOYSA-N 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000004098 Tetracycline Substances 0.000 claims description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims description 4
- 229960003405 ciprofloxacin Drugs 0.000 claims description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 229960002180 tetracycline Drugs 0.000 claims description 4
- 229930101283 tetracycline Natural products 0.000 claims description 4
- 235000019364 tetracycline Nutrition 0.000 claims description 4
- 239000011715 vitamin B12 Substances 0.000 claims description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims description 4
- 229920001744 Polyaldehyde Polymers 0.000 claims description 3
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 claims description 3
- 229960005542 ethidium bromide Drugs 0.000 claims description 3
- 150000003522 tetracyclines Chemical class 0.000 claims description 3
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims description 2
- QHQSCKLPDVSEBJ-UHFFFAOYSA-N 1,3,5-tri(4-aminophenyl)benzene Chemical compound C1=CC(N)=CC=C1C1=CC(C=2C=CC(N)=CC=2)=CC(C=2C=CC(N)=CC=2)=C1 QHQSCKLPDVSEBJ-UHFFFAOYSA-N 0.000 claims description 2
- WJHRAPYKYJKACM-UHFFFAOYSA-N 2,3,5,6-tetrafluoroterephthalaldehyde Chemical compound FC1=C(F)C(C=O)=C(F)C(F)=C1C=O WJHRAPYKYJKACM-UHFFFAOYSA-N 0.000 claims description 2
- VSUKSWCSOBXUFG-UHFFFAOYSA-N 2,5-dibromoterephthalaldehyde Chemical compound BrC1=CC(C=O)=C(Br)C=C1C=O VSUKSWCSOBXUFG-UHFFFAOYSA-N 0.000 claims description 2
- XBCGIUJJUZHWMC-UHFFFAOYSA-N 2,5-dichloroterephthalaldehyde Chemical compound ClC1=CC(C=O)=C(Cl)C=C1C=O XBCGIUJJUZHWMC-UHFFFAOYSA-N 0.000 claims description 2
- QIUMSVLKXTWDSN-UHFFFAOYSA-N 2,5-difluoroterephthalaldehyde Chemical compound FC1=CC(C=O)=C(F)C=C1C=O QIUMSVLKXTWDSN-UHFFFAOYSA-N 0.000 claims description 2
- YSIIHTHHMPYKFP-UHFFFAOYSA-N 2,5-dimethoxyterephthalaldehyde Chemical compound COC1=CC(C=O)=C(OC)C=C1C=O YSIIHTHHMPYKFP-UHFFFAOYSA-N 0.000 claims description 2
- AIBJDPZNCNFKMR-UHFFFAOYSA-N 2,5-dimethylterephthalaldehyde Chemical compound CC1=CC(C=O)=C(C)C=C1C=O AIBJDPZNCNFKMR-UHFFFAOYSA-N 0.000 claims description 2
- DFIOBSJHIZBUCE-UHFFFAOYSA-N 2-hydroxyterephthalaldehyde Chemical compound OC1=CC(C=O)=CC=C1C=O DFIOBSJHIZBUCE-UHFFFAOYSA-N 0.000 claims description 2
- KYERQSUZHFINIE-UHFFFAOYSA-N 4-[2,4,5-tris(4-formylphenyl)phenyl]benzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC(C=2C=CC(C=O)=CC=2)=C(C=2C=CC(C=O)=CC=2)C=C1C1=CC=C(C=O)C=C1 KYERQSUZHFINIE-UHFFFAOYSA-N 0.000 claims description 2
- SNLFYGIUTYKKOE-UHFFFAOYSA-N 4-n,4-n-bis(4-aminophenyl)benzene-1,4-diamine Chemical compound C1=CC(N)=CC=C1N(C=1C=CC(N)=CC=1)C1=CC=C(N)C=C1 SNLFYGIUTYKKOE-UHFFFAOYSA-N 0.000 claims description 2
- YCZUWQOJQGCZKG-UHFFFAOYSA-N 9h-carbazole-3,6-diamine Chemical compound C1=C(N)C=C2C3=CC(N)=CC=C3NC2=C1 YCZUWQOJQGCZKG-UHFFFAOYSA-N 0.000 claims description 2
- REPFNYFEIOZRLM-UHFFFAOYSA-N chembl376444 Chemical compound C1=CC(N)=CC=C1C(C1=CC=C(N1)C(C=1C=CC(N)=CC=1)=C1C=CC(=N1)C(C=1C=CC(N)=CC=1)=C1C=CC(N1)=C1C=2C=CC(N)=CC=2)=C2N=C1C=C2 REPFNYFEIOZRLM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000356 contaminant Substances 0.000 claims description 2
- VKIRRGRTJUUZHS-UHFFFAOYSA-N cyclohexane-1,4-diamine Chemical compound NC1CCC(N)CC1 VKIRRGRTJUUZHS-UHFFFAOYSA-N 0.000 claims description 2
- PKWIYNIDEDLDCJ-UHFFFAOYSA-N guanazole Chemical compound NC1=NNC(N)=N1 PKWIYNIDEDLDCJ-UHFFFAOYSA-N 0.000 claims description 2
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims description 2
- 229940081623 rose bengal Drugs 0.000 claims description 2
- 229930187593 rose bengal Natural products 0.000 claims description 2
- AZJPTIGZZTZIDR-UHFFFAOYSA-L rose bengal Chemical compound [K+].[K+].[O-]C(=O)C1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1C1=C2C=C(I)C(=O)C(I)=C2OC2=C(I)C([O-])=C(I)C=C21 AZJPTIGZZTZIDR-UHFFFAOYSA-L 0.000 claims description 2
- STRXNPAVPKGJQR-UHFFFAOYSA-N rose bengal A Natural products O1C(=O)C(C(=CC=C2Cl)Cl)=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 STRXNPAVPKGJQR-UHFFFAOYSA-N 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- UBKNFAFBINVTOP-UHFFFAOYSA-N thieno[3,2-b]thiophene-2,5-dicarbaldehyde Chemical compound S1C(C=O)=CC2=C1C=C(C=O)S2 UBKNFAFBINVTOP-UHFFFAOYSA-N 0.000 claims description 2
- MBYLVOKEDDQJDY-UHFFFAOYSA-N tris(2-aminoethyl)amine Chemical compound NCCN(CCN)CCN MBYLVOKEDDQJDY-UHFFFAOYSA-N 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Substances C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 7
- 150000001447 alkali salts Chemical class 0.000 claims 4
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 claims 2
- PIWMYUGNZBJTID-UHFFFAOYSA-N 2,5-dihydroxyterephthalaldehyde Chemical compound OC1=CC(C=O)=C(O)C=C1C=O PIWMYUGNZBJTID-UHFFFAOYSA-N 0.000 claims 1
- HDGLPTVARHLGMV-UHFFFAOYSA-N 2-amino-4-(1,1,1,3,3,3-hexafluoropropan-2-yl)phenol Chemical compound NC1=CC(C(C(F)(F)F)C(F)(F)F)=CC=C1O HDGLPTVARHLGMV-UHFFFAOYSA-N 0.000 claims 1
- UBDZFAGVPPMTIT-UHFFFAOYSA-N 2-aminoguanidine;hydron;chloride Chemical compound [Cl-].NC(N)=N[NH3+] UBDZFAGVPPMTIT-UHFFFAOYSA-N 0.000 claims 1
- 229910017917 NH4 Cl Inorganic materials 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- JZRYQZJSTWVBBD-UHFFFAOYSA-N pentaporphyrin i Chemical compound N1C(C=C2NC(=CC3=NC(=C4)C=C3)C=C2)=CC=C1C=C1C=CC4=N1 JZRYQZJSTWVBBD-UHFFFAOYSA-N 0.000 claims 1
- 125000003258 trimethylene group Chemical group [H]C([H])([*:2])C([H])([H])C([H])([H])[*:1] 0.000 claims 1
- 239000012071 phase Substances 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 9
- 230000000694 effects Effects 0.000 abstract description 4
- 238000006116 polymerization reaction Methods 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 abstract 2
- 238000006068 polycondensation reaction Methods 0.000 abstract 1
- 238000007873 sieving Methods 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 description 25
- 239000011259 mixed solution Substances 0.000 description 18
- 238000009210 therapy by ultrasound Methods 0.000 description 16
- 239000008367 deionised water Substances 0.000 description 13
- 229910021641 deionized water Inorganic materials 0.000 description 13
- 238000001878 scanning electron micrograph Methods 0.000 description 12
- JPYHHZQJCSQRJY-UHFFFAOYSA-N Phloroglucinol Natural products CCC=CCC=CCC=CCC=CCCCCC(=O)C1=C(O)C=C(O)C=C1O JPYHHZQJCSQRJY-UHFFFAOYSA-N 0.000 description 11
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 11
- QCDYQQDYXPDABM-UHFFFAOYSA-N phloroglucinol Chemical compound OC1=CC(O)=CC(O)=C1 QCDYQQDYXPDABM-UHFFFAOYSA-N 0.000 description 11
- 229960001553 phloroglucinol Drugs 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 229910052938 sodium sulfate Inorganic materials 0.000 description 11
- 235000011152 sodium sulphate Nutrition 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 9
- 239000011148 porous material Substances 0.000 description 8
- 229920000620 organic polymer Polymers 0.000 description 7
- 239000003960 organic solvent Substances 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 241000220317 Rosa Species 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- OJUDFURAIYFYBP-UHFFFAOYSA-N (dihydrazinylmethylideneamino)azanium;chloride Chemical compound Cl.NNC(NN)=NN OJUDFURAIYFYBP-UHFFFAOYSA-N 0.000 description 4
- MBJAPGAZEWPEFB-UHFFFAOYSA-N 5-amino-2-(4-amino-2-sulfophenyl)benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC(N)=CC=C1C1=CC=C(N)C=C1S(O)(=O)=O MBJAPGAZEWPEFB-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 229920006254 polymer film Polymers 0.000 description 4
- 238000002525 ultrasonication Methods 0.000 description 4
- 238000012695 Interfacial polymerization Methods 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 238000012512 characterization method Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000011056 performance test Methods 0.000 description 3
- 239000002861 polymer material Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- QMKYBPDZANOJGF-UHFFFAOYSA-N benzene-1,3,5-tricarboxylic acid Chemical compound OC(=O)C1=CC(C(O)=O)=CC(C(O)=O)=C1 QMKYBPDZANOJGF-UHFFFAOYSA-N 0.000 description 2
- HFACYLZERDEVSX-UHFFFAOYSA-N benzidine Chemical compound C1=CC(N)=CC=C1C1=CC=C(N)C=C1 HFACYLZERDEVSX-UHFFFAOYSA-N 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- JQXXHWHPUNPDRT-YOPQJBRCSA-N chembl1332716 Chemical compound O([C@](C1=O)(C)O\C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)/C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CCN(C)CC1 JQXXHWHPUNPDRT-YOPQJBRCSA-N 0.000 description 2
- 238000010406 interfacial reaction Methods 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000002957 persistent organic pollutant Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 229960001225 rifampicin Drugs 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- QWEDOJNFSGBCCP-UHFFFAOYSA-N 2,3,4-trihydroxy-5-thiophen-3-ylcyclohepta-2,4,6-trien-1-one Chemical compound C1=CC(=O)C(O)=C(O)C(O)=C1C1=CSC=C1 QWEDOJNFSGBCCP-UHFFFAOYSA-N 0.000 description 1
- MSTZGVRUOMBULC-UHFFFAOYSA-N 2-amino-4-[2-(3-amino-4-hydroxyphenyl)-1,1,1,3,3,3-hexafluoropropan-2-yl]phenol Chemical compound C1=C(O)C(N)=CC(C(C=2C=C(N)C(O)=CC=2)(C(F)(F)F)C(F)(F)F)=C1 MSTZGVRUOMBULC-UHFFFAOYSA-N 0.000 description 1
- IIQLVLWFQUUZII-UHFFFAOYSA-N 2-amino-5-(4-amino-3-carboxyphenyl)benzoic acid Chemical compound C1=C(C(O)=O)C(N)=CC=C1C1=CC=C(N)C(C(O)=O)=C1 IIQLVLWFQUUZII-UHFFFAOYSA-N 0.000 description 1
- HKAZHQGKWVMFHP-UHFFFAOYSA-N 2-hydroxybenzene-1,3,5-tricarbaldehyde Chemical compound OC1=C(C=O)C=C(C=O)C=C1C=O HKAZHQGKWVMFHP-UHFFFAOYSA-N 0.000 description 1
- VSAJQHOWBINJEV-UHFFFAOYSA-N 2-pyridin-2-yl-3h-pyridine-4,4-dicarbaldehyde Chemical compound C1=CC(C=O)(C=O)CC(C=2N=CC=CC=2)=N1 VSAJQHOWBINJEV-UHFFFAOYSA-N 0.000 description 1
- FEHLIYXNTWAEBQ-UHFFFAOYSA-N 4-(4-formylphenyl)benzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC=C(C=O)C=C1 FEHLIYXNTWAEBQ-UHFFFAOYSA-N 0.000 description 1
- LKNZAROPNWYSST-UHFFFAOYSA-N 4-[10,15,20-tris(4-formylphenyl)-21,23-dihydroporphyrin-5-yl]benzaldehyde Chemical compound O=Cc1ccc(cc1)-c1c2ccc(n2)c(-c2ccc(C=O)cc2)c2ccc([nH]2)c(-c2ccc(C=O)cc2)c2ccc(n2)c(-c2ccc(C=O)cc2)c2ccc1[nH]2 LKNZAROPNWYSST-UHFFFAOYSA-N 0.000 description 1
- KIFDSGGWDIVQGN-UHFFFAOYSA-N 4-[9-(4-aminophenyl)fluoren-9-yl]aniline Chemical compound C1=CC(N)=CC=C1C1(C=2C=CC(N)=CC=2)C2=CC=CC=C2C2=CC=CC=C21 KIFDSGGWDIVQGN-UHFFFAOYSA-N 0.000 description 1
- MKHDOBRSMHTMOK-UHFFFAOYSA-N 5-amino-2-(4-amino-2-carboxyphenyl)benzoic acid Chemical compound OC(=O)C1=CC(N)=CC=C1C1=CC=C(N)C=C1C(O)=O MKHDOBRSMHTMOK-UHFFFAOYSA-N 0.000 description 1
- OYFRNYNHAZOYNF-UHFFFAOYSA-N H2dhybdc Natural products OC(=O)C1=CC(O)=C(C(O)=O)C=C1O OYFRNYNHAZOYNF-UHFFFAOYSA-N 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- AEKQNAANFVOBCU-UHFFFAOYSA-N benzene-1,3,5-tricarbaldehyde Chemical compound O=CC1=CC(C=O)=CC(C=O)=C1 AEKQNAANFVOBCU-UHFFFAOYSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000598 endocrine disruptor Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 231100000086 high toxicity Toxicity 0.000 description 1
- 238000002173 high-resolution transmission electron microscopy Methods 0.000 description 1
- 150000007857 hydrazones Chemical class 0.000 description 1
- 150000002466 imines Chemical class 0.000 description 1
- 239000003317 industrial substance Substances 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- RUTXIHLAWFEWGM-UHFFFAOYSA-H iron(3+) sulfate Chemical compound [Fe+3].[Fe+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O RUTXIHLAWFEWGM-UHFFFAOYSA-H 0.000 description 1
- 229910000360 iron(III) sulfate Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003075 phytoestrogen Substances 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- OFVLGDICTFRJMM-WESIUVDSSA-N tetracycline Chemical compound C1=CC=C2[C@](O)(C)[C@H]3C[C@H]4[C@H](N(C)C)C(O)=C(C(N)=O)C(=O)[C@@]4(O)C(O)=C3C(=O)C2=C1O OFVLGDICTFRJMM-WESIUVDSSA-N 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G12/00—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen
- C08G12/02—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes
- C08G12/04—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with acyclic or carbocyclic compounds
- C08G12/06—Amines
- C08G12/08—Amines aromatic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0006—Organic membrane manufacture by chemical reactions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/72—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, not provided for in a single one of the groups B01D71/46 - B01D71/70 and B01D71/701 - B01D71/702
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F1/00—Treatment of water, waste water, or sewage
- C02F1/44—Treatment of water, waste water, or sewage by dialysis, osmosis or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
-
- C—CHEMISTRY; METALLURGY
- C02—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F—TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE
- C02F2101/00—Nature of the contaminant
- C02F2101/30—Organic compounds
- C02F2101/308—Dyes; Colorants; Fluorescent agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2361/00—Characterised by the use of condensation polymers of aldehydes or ketones; Derivatives of such polymers
- C08J2361/20—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen
- C08J2361/22—Condensation polymers of aldehydes or ketones with only compounds containing hydrogen attached to nitrogen of aldehydes with acyclic or carbocyclic compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Manufacturing & Machinery (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Environmental & Geological Engineering (AREA)
- Materials Engineering (AREA)
- Water Supply & Treatment (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hydrology & Water Resources (AREA)
- Manufacture Of Macromolecular Shaped Articles (AREA)
Abstract
本发明公开了一种不对称自支撑共价有机框架薄膜的制备方法及其应用,通过水相‑有机相两相界面法,含有胺单体的水相与含有醛单体的有机相在界面发生缩聚反应,得到不对称自支撑共价有机框架薄膜;在水相体系中添加有无机盐,通过加速水相中胺单体传质和配位预组装协同作用加速胺单体与有机相中的醛单体反应。本发明方案通过无机盐的推动作用,使得常温常压下不能进行的聚合反应得以进行,反应速率快,产率高。此外,本发明制备的共价有机框架薄膜具有结晶性好,孔隙率高,机械性能和化学稳定性好的特点,同时拥有优异的分子筛分能力。
The invention discloses a method for preparing an asymmetric self-supporting covalent organic framework film and its application. By a water-organic phase two-phase interface method, a water phase containing amine monomers and an organic phase containing aldehyde monomers undergo polycondensation reaction at the interface to obtain an asymmetric self-supporting covalent organic framework film; an inorganic salt is added to the water phase system, and the reaction of the amine monomers with the aldehyde monomers in the organic phase is accelerated by accelerating the mass transfer of the amine monomers in the water phase and the synergistic effect of the coordinated pre-assembly. The scheme of the present invention enables the polymerization reaction that cannot be carried out at room temperature and pressure to be carried out through the driving effect of the inorganic salt, with a fast reaction rate and high yield. In addition, the covalent organic framework film prepared by the present invention has the characteristics of good crystallinity, high porosity, good mechanical properties and chemical stability, and excellent molecular sieving ability.
Description
技术领域Technical Field
本发明属于新材料膜技术领域,尤其涉及一种不对称自支撑共价有机框架薄膜的制备方法及其应用。The invention belongs to the technical field of new material films, and in particular relates to a preparation method of an asymmetric self-supporting covalent organic framework film and an application thereof.
背景技术Background technique
共价有机框架高分子材料(COFs)作为新一代晶体框架聚合物材料,被认为是21世纪最先进的材料之一,它具有超高的比表面积,规则和周期性的孔结构,较窄的孔径分布,良好的化学稳定性和优良的可设计性,构筑基元化学结构多样性,赋予COF多样的拓扑结构,孔径可在亚纳米尺度上精密调控,同时易于功能化,赋予COFs新的功能。COFs聚合物材料被广泛地用于吸附,分离,催化,质子传导等方面。Covalent organic framework polymer materials (COFs) are a new generation of crystalline framework polymer materials and are considered to be one of the most advanced materials in the 21st century. They have ultra-high specific surface area, regular and periodic pore structure, narrow pore size distribution, good chemical stability and excellent designability. The diversity of the basic chemical structure gives COF a variety of topological structures. The pore size can be precisely controlled at the sub-nanometer scale. At the same time, it is easy to functionalize and give COFs new functions. COFs polymer materials are widely used in adsorption, separation, catalysis, proton conduction and other aspects.
有机染料和新出现的痕量有机污染物(TrOCs)等有机污染物对天然水道和水生生态系统的影响日益严重,对人类健康和水生环境的健康造成了潜在威胁,这引起了人们的极大关注。特别值得关注的是TrOCs,这是一类目前缺乏相关环境管理政策或排放标准的污染物。这些污染物包括类固醇激素、植物雌激素、干扰内分泌的化学品、药物和个人护理产品、工业化学品、消毒副产品和杀虫剂等。由于分子量小、毒性大、耐久性强,TrOCs很难从水生环境中去除。There is great concern about the increasing impacts of organic pollutants such as organic dyes and emerging trace organic contaminants (TrOCs) on natural waterways and aquatic ecosystems, posing potential threats to human health and the health of the aquatic environment. Of particular concern are TrOCs, a class of pollutants that currently lacks relevant environmental management policies or emission standards. These pollutants include steroid hormones, phytoestrogens, endocrine disrupting chemicals, pharmaceuticals and personal care products, industrial chemicals, disinfection by-products, and pesticides. Due to their small molecular weight, high toxicity, and high durability, TrOCs are difficult to remove from aquatic environments.
膜技术为从水环境中去除这些污染物提供了一种前景广阔的可持续方法。然而,大多数商用膜的孔径大于大多数痕量有机污染物的分子尺寸,因此实现有效拦截具有挑战性。目前的COFs膜在剔除水和有机溶剂中的污染物(如染料、药物和水合离子)方面表现出卓越的能力。然而,COFs骨架由通常为0.8至5纳米的构建单元组成,其固有的孔径给通过COFs通道识别较小的TrOC带来了挑战。Membrane technology offers a promising and sustainable approach to remove these pollutants from aqueous environments. However, the pore size of most commercial membranes is larger than the molecular size of most trace organic pollutants, making effective interception challenging. Current COFs membranes have demonstrated excellent capabilities in removing pollutants such as dyes, drugs, and hydrated ions from water and organic solvents. However, the COFs backbone is composed of building blocks that are typically 0.8 to 5 nanometers, and their inherent pore size poses a challenge to the recognition of smaller TrOCs through COFs channels.
大部分COFs反应需要在高温高压条件下进行反应,而且得到粉体材料,很难进行多次重复使用。COFs膜作为一种新兴膜材料能够多次重复使用,可回收,具有巨大的应用前景。COFs膜种类主要根据不同的成键类型分为亚胺类,三嗪类,SP2类,腙类,硼酸酯类等等,这些类型的COFs膜往往需要高温高压以及催化剂存在下才能反应,对COFs的制备带来了巨大的困难。其中,对于离子型COFs膜制备的难度远远大于非离子型COFs膜。一般而言,用于制造非离子型COFs膜的界面聚合技术很难直接迁移到离子型COFs膜制造中。根据文献报道,通过界面聚合策略制备的离子型COFs膜至少耗时15天,并且得到的离子型COFs膜结晶性十分地差,更有甚者,离子型COFs膜根本不能够得到。单体携带的离子基团的强吸电子作以及空间位阻效应,大大降低了单体的反应活性,从而无法通过界面反应制备COFs膜。此外常规方法得到的COFs膜是对称性的,这种对称性是不利于分子分离的。Most COFs reactions need to be carried out under high temperature and high pressure conditions, and the powder materials obtained are difficult to reuse multiple times. As an emerging membrane material, COFs membrane can be reused multiple times and is recyclable, with great application prospects. COFs membrane types are mainly divided into imines, triazines, SP2 , hydrazones, borate esters, etc. according to different bonding types. These types of COFs membranes often require high temperature and high pressure and the presence of catalysts to react, which brings great difficulties to the preparation of COFs. Among them, the difficulty of preparing ionic COFs membranes is much greater than that of non-ionic COFs membranes. Generally speaking, the interfacial polymerization technology used to manufacture non-ionic COFs membranes is difficult to directly migrate to the manufacture of ionic COFs membranes. According to literature reports, the preparation of ionic COFs membranes by interfacial polymerization strategies takes at least 15 days, and the crystallinity of the obtained ionic COFs membranes is very poor. What's more, ionic COFs membranes cannot be obtained at all. The strong electron-withdrawing action and steric hindrance effect of the ionic groups carried by the monomers greatly reduce the reaction activity of the monomers, making it impossible to prepare COFs membranes by interfacial reactions. In addition, the COFs film obtained by conventional methods is symmetrical, which is not conducive to molecular separation.
上述公开于该背景技术部分的信息仅仅旨在增加对本发明的总体背景的理解,而不应当被视为承认或以任何形式暗示该信息构成已为本领域一般技术人员所公知的现有技术。The above information disclosed in this background technology section is only intended to increase the understanding of the overall background of the present invention, and should not be regarded as acknowledging or suggesting in any form that the information constitutes the prior art already known to ordinary technicians in this field.
发明内容Summary of the invention
本发明针对上述现有技术的不足,提供了一种不对称自支撑共价有机框架薄膜的制备方法及其应用。本发明制备不对称COFs膜的方法简便可控,效率高,产品质量优异,制备的COFs膜具备高的结晶度、优异的稳定性以及成膜性。与此同时,COFs膜具有不对称的特殊结构,这种不对称结构会增加上下表面的孔径梯度差,有利于强化分子分离时通量增加,同时兼具优异的分子筛分能力。In view of the deficiencies of the above-mentioned prior art, the present invention provides a method for preparing an asymmetric self-supporting covalent organic framework film and its application. The method for preparing an asymmetric COFs membrane of the present invention is simple and controllable, with high efficiency and excellent product quality. The prepared COFs membrane has high crystallinity, excellent stability and film-forming properties. At the same time, the COFs membrane has a special asymmetric structure, which increases the pore size gradient difference between the upper and lower surfaces, which is beneficial to increase the flux when strengthening molecular separation, and at the same time has excellent molecular screening ability.
本发明不对称自支撑共价有机框架薄膜的制备方法,通过水相-有机相两相界面法,含有胺单体的水相与含有醛单体的有机相在界面发生缩聚反应得到;在水相体系中添加有无机盐,通过加速水相中胺单体传质和配位预组装协同作用加速胺单体与有机相中的醛单体反应。The preparation method of the asymmetric self-supporting covalent organic framework film of the present invention is obtained by a water-organic phase two-phase interface method, wherein a water phase containing amine monomers and an organic phase containing aldehyde monomers undergo condensation polymerization at the interface; an inorganic salt is added to the water phase system, and the reaction of the amine monomers with the aldehyde monomers in the organic phase is accelerated by accelerating the mass transfer of the amine monomers in the water phase and the synergistic effect of coordination preassembly.
所述胺单体为带有阴离子基团(包括-SO3H等阴离子基团)、阳离子基团(-N+等)或者中性基团的胺单体。The amine monomer is an amine monomer having an anionic group (including anionic groups such as -SO 3 H), a cationic group (such as -N + ) or a neutral group.
进一步,所述胺单体选自2 ,5-二氨基苯磺酸、2,4-二氨基苯磺酸、4,4'-二氨基联苯-2,2'-二羧酸、4,4'-二氨基联苯-2,2'-二磺酸、4,4'-二氨基-1,1'-联苯-3,3'-二羧酸、对苯二胺、4,4'-联苯二胺、3,5-二氨基-1,2,4-三氮唑、9H-咔唑-3,6-二胺、4,4'-偶氮二苯胺、1,3,5-三(4-氨苯基)苯、5,10,15,20-四(4-氨基苯基)卟啉、三(4-氨基苯基)胺、反式-1,4-环己二胺、2,2-双(3-氨基-4-羟基苯基)六氟丙烷、9,9-双(4-氨基苯基)芴、溴化乙啶、三氨基胍盐酸盐、水合肼、三(2-氨基乙基)胺中的一种。Further, the amine monomer is selected from 2,5-diaminobenzenesulfonic acid, 2,4-diaminobenzenesulfonic acid, 4,4'-diaminobiphenyl-2,2'-dicarboxylic acid, 4,4'-diaminobiphenyl-2,2'-disulfonic acid, 4,4'-diamino-1,1'-biphenyl-3,3'-dicarboxylic acid, p-phenylenediamine, 4,4'-biphenylenediamine, 3,5-diamino-1,2,4-triazole, 9H-carbazole-3,6-diamine, 4,4'- One of azodiphenylamine, 1,3,5-tri(4-aminophenyl)benzene, 5,10,15,20-tetrakis(4-aminophenyl)porphyrin, tri(4-aminophenyl)amine, trans-1,4-cyclohexanediamine, 2,2-bis(3-amino-4-hydroxyphenyl)hexafluoropropane, 9,9-bis(4-aminophenyl)fluorene, ethidium bromide, triaminoguanidine hydrochloride, hydrazine hydrate, and tri(2-aminoethyl)amine.
更进一步,所述胺单体为2 ,5-二氨基苯磺酸、2,4-二氨基苯磺酸、4,4'-二氨基联苯-2,2'-二磺酸、对苯二胺、4,4'-联苯二胺、溴化乙啶或三氨基胍盐酸盐。Furthermore, the amine monomer is 2,5-diaminobenzenesulfonic acid, 2,4-diaminobenzenesulfonic acid, 4,4'-diaminobiphenyl-2,2'-disulfonic acid, p-phenylenediamine, 4,4'-biphenylenediamine, ethidium bromide or triaminoguanidine hydrochloride.
所述醛单体选自三醛基间苯三酚、均苯三甲醛、噻吩并[3,2-b]噻吩-2,5-二羧醛、2-羟基-1,3,5-苯三甲醛、2-羟基苯-1,4-二甲醛、2,5-二氟对苯二甲醛、2,5-二甲氧基苯-1,4-二甲醛、2,5-二氯对苯二甲醛、2,5-二溴苯-1,4-二甲醛、2,5-二甲基对苯二甲醛、四氟对苯二甲醛、5,10,15,20-四(4-醛基苯)-21H,23H-卟啉、4,4’-联苯二甲醛、2,5-二羟基-1,4-苯二羧醛、2,2-联吡啶-4,4-二甲醛、1,2,4,5-四(4-甲酰基苯基)苯、4,4’-(2,2-双((4-甲酰苯氧基)甲基)丙烷-1,3-二基)双(氧基))二苯甲醛中的一种。The aldehyde monomer is selected from the group consisting of trialdehyde phloroglucinol, trimesic acid, thieno[3,2-b]thiophene-2,5-dicarboxaldehyde, 2-hydroxy-1,3,5-benzenetricarboxaldehyde, 2-hydroxybenzene-1,4-dicarboxaldehyde, 2,5-difluoroterephthalaldehyde, 2,5-dimethoxybenzene-1,4-dicarboxaldehyde, 2,5-dichloroterephthalaldehyde, 2,5-dibromobenzene-1,4-dicarboxaldehyde, 2,5-dimethylterephthalaldehyde, tetrafluoroterephthalaldehyde, One of dicarboxaldehyde, 5,10,15,20-tetrakis(4-formylphenyl)-21H,23H-porphyrin, 4,4'-biphenyldicarboxaldehyde, 2,5-dihydroxy-1,4-benzenedicarboxylic acid aldehyde, 2,2-bipyridine-4,4-dicarboxaldehyde, 1,2,4,5-tetrakis(4-formylphenyl)benzene, and 4,4'-(2,2-bis((4-formylphenoxy)methyl)propane-1,3-diyl)bis(oxy))dibenzaldehyde.
进一步,所述所述醛单体为三醛基间苯三酚或均苯三甲醛。Furthermore, the aldehyde monomer is trialdehyde phloroglucinol or trimesaldehyde.
所述有机相的溶剂均为二氯甲烷。The solvent of the organic phase is dichloromethane.
所述无机盐易溶于水。The inorganic salt is easily soluble in water.
本发明不对称自支撑共价有机框架薄膜的制备方法,包括如下步骤:The method for preparing the asymmetric self-supporting covalent organic framework film of the present invention comprises the following steps:
步骤1:将胺单体、无机盐分别溶于水溶液中,然后将二者混合,获得水相溶液,其中无机盐提供驱动力推动胺单体加速传质;将多元醛溶于二氯甲烷中,获得有机相溶液;Step 1: dissolving the amine monomer and the inorganic salt in an aqueous solution respectively, and then mixing the two to obtain an aqueous phase solution, wherein the inorganic salt provides a driving force to promote the amine monomer to accelerate mass transfer; dissolving the polyaldehyde in dichloromethane to obtain an organic phase solution;
步骤2:向反应器中加入有机相溶液,然后取水相溶液沿反应器边缘缓慢加入到有机相溶液上方,在室温下静置反应0.5-12小时;Step 2: Add the organic phase solution to the reactor, then slowly add the aqueous phase solution along the edge of the reactor to the top of the organic phase solution, and let it stand at room temperature for 0.5-12 hours;
步骤3:吸取出反应体系中的水和二氯甲烷溶液,得到界面处的共价有机框架高分子薄膜,分别加入二氯甲烷、乙醇和水溶液洗去多余单体、盐和溶剂,然后将膜置于水中,得到离子型或中性共价有机框架高分子膜。Step 3: Aspirate the water and dichloromethane solution in the reaction system to obtain a covalent organic framework polymer film at the interface, add dichloromethane, ethanol and aqueous solution respectively to wash away excess monomers, salts and solvents, and then place the film in water to obtain an ionic or neutral covalent organic framework polymer film.
步骤1中,水相溶液中无机盐的摩尔浓度为1-10mmol/L,胺单体的摩尔浓度为0.1-9 mmol/L。有机相溶液中多元醛单体的摩尔浓度为0.1-9 mmol/L。In step 1, the molar concentration of the inorganic salt in the aqueous phase solution is 1-10 mmol/L, the molar concentration of the amine monomer is 0.1-9 mmol/L, and the molar concentration of the polyaldehyde monomer in the organic phase solution is 0.1-9 mmol/L.
进一步,胺单体和醛单体的摩尔比优选为3:2。Furthermore, the molar ratio of the amine monomer to the aldehyde monomer is preferably 3:2.
步骤1中,所述无机盐为强酸强碱盐或强酸弱碱盐,所述强酸强碱盐选自Na2SO4、NaCl、NaNO3中的一种或多种,所述强酸弱碱盐选自(NH4)2SO4、NH4NO3、NH4Cl中的一种或多种。In step 1, the inorganic salt is a strong acid-strong base salt or a strong acid-weak base salt, the strong acid-strong base salt is selected from one or more of Na 2 SO 4 , NaCl, and NaNO 3 , and the strong acid-weak base salt is selected from one or more of (NH 4 ) 2 SO 4 , NH 4 NO 3 , and NH 4 Cl.
步骤1中,无机盐与水的比率有限制,优选为(1mmol:80mL)~(10mmol:40mL)。In step 1, the ratio of the inorganic salt to water is limited, and is preferably (1 mmol: 80 mL) to (10 mmol: 40 mL).
步骤1中,无机盐与胺单体的摩尔比优选为为(1-5):1。In step 1, the molar ratio of the inorganic salt to the amine monomer is preferably (1-5):1.
步骤2中,水相体积和有机相相体积的比例为40-50mL:30-45mL,比如40 mL:30mL,40 mL:35 mL,40 mL:40 mL,50 mL:45 mL,50 mL:40 mL。In step 2, the ratio of the volume of the aqueous phase to the volume of the organic phase is 40-50 mL:30-45 mL, for example, 40 mL:30 mL, 40 mL:35 mL, 40 mL:40 mL, 50 mL:45 mL, 50 mL:40 mL.
本发明制备的不对称自支撑共价有机框架薄膜在污染物分离中的应用。The invention discloses an application of the asymmetric self-supporting covalent organic framework film prepared by the invention in pollutant separation.
进一步,所述污染物分离包括有机染料、药物分子等的分离。Furthermore, the pollutant separation includes separation of organic dyes, drug molecules, etc.
进一步,所述有机染料包括活性绿、玫瑰红、亮蓝、活性黑、刚果红、靛蓝、甲基橙等中的一种或多种;所述药物分子包括四环素、环丙沙星、维生素B12等中的一种或多种。Furthermore, the organic dye includes one or more of reactive green, rose bengal, brilliant blue, reactive black, Congo red, indigo, methyl orange, etc.; the drug molecule includes one or more of tetracycline, ciprofloxacin, vitamin B12, etc.
与现有技术相比,本发明的有益效果体现在:Compared with the prior art, the beneficial effects of the present invention are as follows:
本发明采用单体与盐的静电作用加速单体传质和界面预组装策略界面聚合法,将胺单体溶解在水相中,然后添加强酸强碱盐或者强酸弱碱盐强化传质;将醛单体溶解在有机相中;然后将两相溶液混合,两种单体在界面处快速反应生长成阴离子、阳离子、中性不对称共价有机高分子膜。与现有技术相比,界面反应得到加速,能够在0.5-12小时内合成出阴离子、阳离子、中性共价有机高分子膜。对于特定胺单体和醛单体,在制备膜材料时,获得的分离能力主要依赖于:膜的成膜性、膜的结晶性、膜的孔径以及膜的厚度。The present invention adopts the electrostatic effect of monomers and salts to accelerate monomer mass transfer and interface pre-assembly strategy interfacial polymerization method, dissolves amine monomers in the aqueous phase, then adds strong acid and strong base salt or strong acid and weak base salt to strengthen mass transfer; dissolves aldehyde monomers in the organic phase; then mixes the two-phase solution, and the two monomers react rapidly at the interface to grow into anionic, cationic, and neutral asymmetric covalent organic polymer membranes. Compared with the prior art, the interfacial reaction is accelerated, and anionic, cationic, and neutral covalent organic polymer membranes can be synthesized within 0.5-12 hours. For specific amine monomers and aldehyde monomers, when preparing membrane materials, the separation ability obtained mainly depends on: the film-forming property of the membrane, the crystallinity of the membrane, the pore size of the membrane, and the thickness of the membrane.
通过本发明方法得到的COFs具有不对称结构,能够增加COFs孔径的梯度差,强化膜的流体的传输。制膜方法简便可控,制备出来的共价有机高分子膜具备高结晶度和成膜性,并且展现出优异的分子分离能力。The COFs obtained by the method of the present invention have an asymmetric structure, which can increase the gradient difference of the COFs pore size and strengthen the transmission of the fluid in the membrane. The membrane preparation method is simple and controllable, and the prepared covalent organic polymer membrane has high crystallinity and film-forming properties, and exhibits excellent molecular separation ability.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1是TpDa-SO3H阴离子不对称共价有机框架高分子膜的表征。(a)TpDa-SO3H阴离子不对称共价有机框架高分子膜粗糙的上表面SEM图片;(b)TpDa-SO3H阴离子共价有机框架高分子膜光滑的下表面SEM图片;(c) TpDa-SO3H阴离子不对称共价有机框架高分子膜上、下表面交接处的SEM图片;(d) TpDa-SO3H阴离子不对称共价有机框架高分子膜的数码照片;(e) TpDa-SO3H阴离子不对称共价有机框架高分子的化学结构示意图;(f) TpDa-SO3H阴离子不对称共价有机框架高分子膜的XRD衍射曲线。Figure 1 is the characterization of TpDa-SO 3 H anion asymmetric covalent organic framework polymer membrane. (a) SEM image of the rough upper surface of TpDa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (b) SEM image of the smooth lower surface of TpDa-SO 3 H anion covalent organic framework polymer membrane; (c) SEM image of the junction between the upper and lower surfaces of TpDa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (d) Digital photo of TpDa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (e) Schematic diagram of the chemical structure of TpDa-SO 3 H anion asymmetric covalent organic framework polymer; (f) XRD diffraction curve of TpDa-SO 3 H anion asymmetric covalent organic framework polymer membrane.
图2是TpDa-SO3H阴离子共价有机框架高分子膜的分子分离图片,其中分子包括:(a)活性绿[RG];(b)玫瑰红[RB];(c)亮蓝[BBR];(d)活性黑[RB5];(e)刚果红[CR];(f)甲基橙[MO]。测试条件为常温,压力为0.5MPa。Figure 2 is a molecular separation picture of TpDa-SO 3 H anionic covalent organic framework polymer membrane, where the molecules include: (a) reactive green [RG]; (b) rose red [RB]; (c) brilliant blue [BBR]; (d) reactive black [RB5]; (e) Congo red [CR]; (f) methyl orange [MO]. The test conditions are room temperature and pressure of 0.5MPa.
图3是TpPa-SO3H阴离子不对称共价有机框架高分子膜的表征。(a) TpPa-SO3H阴离子不对称共价有机框架高分子膜粗糙的上表面SEM图片;(b) TpPa-SO3H阴离子不对称共价有机框架高分子膜光滑的下表面SEM图片;(c) TpPa-SO3H阴离子不对称共价有机框架高分子膜上、下表面交接处的SEM图片;(d) TpPa-SO3H阴离子不对称共价有机框架高分子膜的数码照片;(e) TpPa-SO3H阴离子不对称共价有机框架高分子的化学结构示意图;(f)TpPa-SO3H阴离子不对称共价有机框架高分子膜的XRD衍射曲线。Figure 3 is the characterization of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane. (a) SEM image of the rough upper surface of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (b) SEM image of the smooth lower surface of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (c) SEM image of the junction between the upper and lower surfaces of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (d) Digital photo of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (e) Schematic diagram of the chemical structure of TpPa-SO 3 H anion asymmetric covalent organic framework polymer; (f) XRD diffraction curve of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane.
图4是TpPa-SO3H阴离子不对称共价有机框架高分子膜的分子分离图片,其中分子包括:(a)活性绿[RG];(b)玫瑰红[RB];(c)亮蓝[BBR];(d)活性黑[RB5];(e)刚果红[CR];(f)靛蓝[IC];(g)甲基橙[MO]。测试条件为常温,压力为0.5MPa。Figure 4 is a molecular separation picture of TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane, where the molecules include: (a) reactive green [RG]; (b) rose red [RB]; (c) brilliant blue [BBR]; (d) reactive black [RB5]; (e) Congo red [CR]; (f) indigo [IC]; (g) methyl orange [MO]. The test conditions are room temperature and pressure of 0.5MPa.
图5是TpBa-SO3H阴离子不对称共价有机框架高分子膜的表征。(a) TpBa-SO3H阴离子共价有机框架高分子膜粗糙的上表面SEM图片;(b) TpBa-SO3H阴离子不对称共价有机框架高分子膜光滑的下表面SEM图片;(c) TpBa-SO3H阴离子不对称共价有机框架高分子膜上、下表面交接处的SEM图片;(d) TpBa-SO3H阴离子不对称共价有机框架高分子膜的数码照片;(e) TpBa-SO3H阴离子不对称共价有机框架高分子的化学结构示意图;(f) TpBa-SO3H阴离子不对称共价有机框架高分子膜的高倍透射电镜图片。Figure 5 is the characterization of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane. (a) SEM image of the rough upper surface of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (b) SEM image of the smooth lower surface of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (c) SEM image of the junction between the upper and lower surfaces of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (d) Digital photo of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane; (e) Schematic diagram of the chemical structure of TpBa-SO 3 H anion asymmetric covalent organic framework polymer; (f) High-magnification transmission electron microscope image of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane.
图6是TpBa-SO3H阴离子不对称共价有机框架高分子膜的分子分离图片,其中分子包括:(a)活性绿[RG];(b)玫瑰红[RB];(c)亮蓝[BBR];(d)活性黑[RB5]。测试条件为常温,压力为0.5MPa。Figure 6 is a molecular separation picture of TpBa-SO 3 H anion asymmetric covalent organic framework polymer membrane, where the molecules include: (a) reactive green [RG]; (b) rose red [RB]; (c) brilliant blue [BBR]; (d) reactive black [RB5]. The test conditions are room temperature and pressure of 0.5MPa.
图7是TpHZ阳离子型共价有机框架高分子膜的分子分离图片,其中分子包括:(a)活性绿[RG];(b)玫瑰红[RB];(c)亮蓝[BBR];(d)活性黑[RB5];(e)刚果红[CR];(f)靛蓝[IC];(g)甲基橙[MO]。测试条件为常温,压力为0.5MPa。Figure 7 is a molecular separation picture of the TpHZ cationic covalent organic framework polymer membrane, where the molecules include: (a) reactive green [RG]; (b) rose red [RB]; (c) brilliant blue [BBR]; (d) reactive black [RB5]; (e) Congo red [CR]; (f) indigo [IC]; (g) methyl orange [MO]. The test conditions are room temperature and pressure of 0.5 MPa.
图8是TpPa中性共价有机框架高分子膜的分子分离图片,其中分子包括:(a)活性绿[RG];(b)玫瑰红[RB];(c)亮蓝[BBR];(d)活性黑[RB5];(e)刚果红[CR];(f)靛蓝[IC];(g)甲基橙[MO]。测试条件为常温,压力为0.5MPa。Figure 8 is a molecular separation picture of TpPa neutral covalent organic framework polymer membrane, where the molecules include: (a) reactive green [RG]; (b) rose red [RB]; (c) brilliant blue [BBR]; (d) reactive black [RB5]; (e) Congo red [CR]; (f) indigo [IC]; (g) methyl orange [MO]. The test conditions are room temperature and pressure of 0.5 MPa.
图9是TpDa-SO3H阴离子共价有机框架高分子膜的药物分子分离图片,其中分子包括:(a)维生素B12[VB12];(b)利福平[RF];(c)四环素[TC];(d)环丙沙星[CF]。测试条件为常温,压力为0.5MPa。Figure 9 is a picture of drug molecule separation of TpDa-SO 3 H anionic covalent organic framework polymer membrane, where the molecules include: (a) vitamin B12 [VB12]; (b) rifampicin [RF]; (c) tetracycline [TC]; (d) ciprofloxacin [CF]. The test conditions are room temperature and pressure of 0.5 MPa.
图10是TpPa中性共价有机框架高分子膜不同时间膜的生长情况。(a)TpPa中性共价有机框架高分子膜随时间变化的数码图片;(b)TpPa(10 mmol Na2SO4)中性共价有机框架高分子膜随时间变化的数码图片。Figure 10 shows the growth of TpPa neutral covalent organic framework polymer membrane at different times. (a) Digital image of TpPa neutral covalent organic framework polymer membrane changing with time; (b) Digital image of TpPa (10 mmol Na 2 SO 4 ) neutral covalent organic framework polymer membrane changing with time.
图11是TpDt阳离子共价有机框架高分子膜不同时间膜的生长情况。(a)TpDt阳离子共价有机框架高分子膜随时间变化的数码图片;(b)TpDt(10 mmol Na2SO4)阳离子共价有机框架高分子膜随时间变化的数码图片。Figure 11 shows the growth of TpDt cationic covalent organic framework polymer membrane at different times. (a) Digital image of TpDt cationic covalent organic framework polymer membrane changing with time; (b) Digital image of TpDt (10 mmol Na 2 SO 4 ) cationic covalent organic framework polymer membrane changing with time.
图12是TpPa-SO3H阴离子不对称共价有机框架高分子膜体系中的传质情况。(a)体系中有/无Na2SO4时,Pa-SO3H在界面传递时吸光度的变化;(b)体系中有Na2SO4时,不同时间吸光度的变化,传递速率k=0.06075 A/min;(c)体系中无Na2SO4时,不同时间吸光度的变化,传递速率k=0.01075 A/min;体系中有Na2SO4时,Pa-SO3H传递速率是无Na2SO4传递速率的5.7倍。Figure 12 shows the mass transfer in the TpPa-SO 3 H anion asymmetric covalent organic framework polymer membrane system. (a) Changes in absorbance of Pa-SO 3 H during interface transfer when there is/is not Na 2 SO 4 in the system; (b) Changes in absorbance at different times when there is Na 2 SO 4 in the system, and the transfer rate k=0.06075 A/min; (c) Changes in absorbance at different times when there is no Na 2 SO 4 in the system, and the transfer rate k=0.01075 A/min; When there is Na 2 SO 4 in the system, the transfer rate of Pa-SO 3 H is 5.7 times that of the transfer rate without Na 2 SO 4 .
具体实施方式Detailed ways
下面结合本发明具体的实施方式,对本发明技术方案进行示例性的详细阐述,但应当理解本发明的保护范围并不受具体实施方式的限制。The technical solution of the present invention is exemplarily described in detail below in conjunction with specific implementation modes of the present invention, but it should be understood that the protection scope of the present invention is not limited by the specific implementation modes.
除非另有其它明确表示,否则在整个说明书和权利要求书中,术语“包括”或其变换如“包含”或“包括有”等等将被理解为包括所陈述的组成部分,而并未排除的其它组成部分。Unless explicitly stated otherwise, throughout the specification and claims, the term "comprise" or variations such as "include" or "comprising" etc., will be understood to include the stated components but not to exclude other components.
实施例1:高结晶度TpDa-SO3H阴离子型不对称共价有机框架高分子膜的制备。Example 1: Preparation of a high-crystallinity TpDa-SO 3 H anionic asymmetric covalent organic framework polymer membrane.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2,4-二氨基苯磺酸(Da-SO3H)和10 mmol硫酸钠(强酸强碱盐)加入到40mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中。将培养皿静置在室温条件下反应12 h得到TpDa-SO3H膜;然后用胶头滴管吸取出上下层的水和有机溶剂,分别加入60 mL二氯甲烷、乙醇和水于培养皿中洗涤6h,去除未反应的单体和有机溶剂,最后将膜放置于去离子水相环境用于后续分子分离。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 2,4-diaminobenzenesulfonic acid (Da-SO 3 H) and 10 mmol of sodium sulfate (strong acid and strong base salt) were added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was allowed to stand at room temperature for 12 h to obtain the TpDa-SO 3 H membrane. Then, the water and organic solvent in the upper and lower layers were sucked out with a rubber-tipped dropper, and 60 mL of dichloromethane, ethanol and water were added to the culture dish for washing for 6 h to remove the unreacted monomers and organic solvents. Finally, the membrane was placed in a deionized water phase environment for subsequent molecular separation.
本实施例样品性能检测如图1-2所示。图1中膜上下表面SEM图像如(a)-(c)所示,(d)膜数码照片展示了TpDa-SO3H优异的成膜性,(e)展示了TpDa-SO3H的化学结构,(f)XRD证明了所制备的TpDa-SO3H离子型共价有机高分子膜具有高结晶度。其分子分离如图2所示,可以看出所制备的TpDa-SO3H膜具有优异的分子分离能力。The performance test of the samples in this embodiment is shown in Figures 1-2. The SEM images of the upper and lower surfaces of the membrane in Figure 1 are shown in (a)-(c), (d) the digital photo of the membrane shows the excellent film-forming property of TpDa-SO 3 H, (e) shows the chemical structure of TpDa-SO 3 H, and (f) XRD proves that the prepared TpDa-SO 3 H ionic covalent organic polymer membrane has high crystallinity. Its molecular separation is shown in Figure 2, and it can be seen that the prepared TpDa-SO 3 H membrane has excellent molecular separation ability.
实施例2:高结晶度TpPa-SO3H阴离子型不对称共价有机框架膜的制备。Example 2: Preparation of a high crystallinity TpPa-SO 3 H anionic asymmetric covalent organic framework membrane.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2,5-二氨基苯磺酸(Pa-SO3H)和10 mmol硫酸钠(强酸强碱盐)加入到40mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中。将培养皿静置在室温条件下反应0.5 h得到TpPa-SO3H膜;然后用胶头滴管吸取出上下层的水和有机溶剂,分别加入60mL二氯甲烷、乙醇和水于培养皿中洗涤6h,去除未反应的单体和有机溶剂,最后将膜放置于去离子水相环境用于后续分子分离。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 2,5-diaminobenzenesulfonic acid (Pa-SO 3 H) and 10 mmol of sodium sulfate (strong acid and strong base salt) were added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was allowed to stand at room temperature for 0.5 h to obtain the TpPa-SO 3 H membrane. Then, the water and organic solvent of the upper and lower layers were sucked out with a rubber-tipped dropper, and 60 mL of dichloromethane, ethanol and water were added to the culture dish for washing for 6 h to remove the unreacted monomers and organic solvents. Finally, the membrane was placed in a deionized water phase environment for subsequent molecular separation.
本实施例样品性能检测如图3-4所示,其中图3中膜上下表面SEM图像如(a)-(c)所示,(d)膜数码照片展示了TpPa-SO3H优异的成膜性,(e)展示了TpPa-SO3H的化学结构,(f )XRD证明了所制备的TpPa-SO3H离子型共价有机高分子膜具有高结晶度。其分子分离如图4所示,可以看出所制备的TpPa-SO3H膜具有优异的分子分离能力。The performance test of the samples in this embodiment is shown in Figures 3-4, where the SEM images of the upper and lower surfaces of the membrane in Figure 3 are shown in (a)-(c), (d) the digital photo of the membrane shows the excellent film-forming property of TpPa-SO 3 H, (e) shows the chemical structure of TpPa-SO 3 H, and (f) XRD proves that the prepared TpPa-SO 3 H ionic covalent organic polymer membrane has high crystallinity. Its molecular separation is shown in Figure 4, and it can be seen that the prepared TpPa-SO 3 H membrane has excellent molecular separation ability.
实施例3:高结晶度TpBa-SO3H阴离子型不对称共价有机框架膜的制备。Example 3: Preparation of TpBa-SO 3 H anionic asymmetric covalent organic framework membrane with high crystallinity.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的4,4'-二氨基联苯-2,2'-二磺酸(Ba-SO3H)和10 mmol硫酸钠(强酸强碱盐)加入到40mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中。将培养皿静置在室温条件下反应12h得到TpBa-SO3H;然后用胶头滴管吸取出上下层的水和有机溶剂,分别加入60 mL二氯甲烷、乙醇和水于培养皿中洗涤6h,去除未反应的单体和有机溶剂,最后将膜放置于去离子水相环境用于后续分子分离。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 4,4'-diaminobiphenyl-2,2'-disulfonic acid (Ba-SO 3 H) and 10 mmol of sodium sulfate (strong acid and strong base salt) were added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was allowed to stand at room temperature for 12 hours to obtain TpBa-SO 3 H. Then, the water and organic solvent in the upper and lower layers were sucked out with a rubber-tipped dropper, and 60 mL of dichloromethane, ethanol and water were added to the culture dish for washing for 6 hours to remove the unreacted monomers and organic solvents. Finally, the membrane was placed in a deionized water phase environment for subsequent molecular separation.
本实施例样品性能检测如图5-6所示,其中图5中膜上下表面SEM图像如(a)-(c)所示,(d)膜数码照片展示了TpBa-SO3H优异的成膜性,(e)展示了TpBa-SO3H的化学结构,图(f)HR-TEM证明了所制备的TpBa-SO3H离子型共价有机高分子膜具有高结晶度。其分子分离如图6所示,可以看出所制备的TpBa-SO3H具有较好的分子分离能力。The performance test of the samples in this embodiment is shown in Figures 5-6, where the SEM images of the upper and lower surfaces of the membrane in Figure 5 are shown in (a)-(c), (d) the digital photo of the membrane shows the excellent film-forming property of TpBa-SO 3 H, (e) shows the chemical structure of TpBa-SO 3 H, and (f) HR-TEM proves that the prepared TpBa-SO 3 H ionic covalent organic polymer membrane has high crystallinity. Its molecular separation is shown in Figure 6, and it can be seen that the prepared TpBa-SO 3 H has good molecular separation ability.
实施例4:有Na2SO4(强酸强碱盐)情况下制备的TpPa中性共价有机框架高分子膜的成膜速度对比。Example 4: Comparison of film formation rates of TpPa neutral covalent organic framework polymer films prepared in the presence of Na 2 SO 4 (strong acid and strong base salt).
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的对苯二胺(Pa)和10 mmol硫酸钠(强酸强碱盐,图10(a)无硫酸钠,图10(b)加入硫酸钠)加入到40 mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相溶液沿培养皿周围缓慢加入到有机相溶液中。观察不同时间的成膜状况,对比可知加入硫酸钠时能够加速TpPa中性共价有机框架高分子成膜。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of p-phenylenediamine (Pa) and 10 mmol of sodium sulfate (strong acid and strong base salt, Figure 10 (a) without sodium sulfate, Figure 10 (b) with sodium sulfate) were added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous phase solution was slowly added to the organic phase solution along the periphery of the culture dish. The film formation conditions at different times were observed, and the comparison showed that the addition of sodium sulfate could accelerate the film formation of TpPa neutral covalent organic framework polymer.
实施例5:有Na2SO4(强酸强碱盐)情况下制备的TpDt阳离子型共价有机框架高分子膜的成膜速度对比。Example 5: Comparison of film formation rates of TpDt cationic covalent organic framework polymer films prepared in the presence of Na 2 SO 4 (strong acid and strong base salt).
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的,三氨基胍盐酸盐(Dt)和10 mmol硫酸钠(强酸强碱盐,图11(a)无硫酸钠,图11(b)加入硫酸钠)加入到40 mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相溶液沿培养皿周围缓慢加入到水相溶液中。观察不同时间的成膜状况,对比可知加入硫酸钠时能够加速TpDt阳离子型共价有机框架高分子成膜。2 mmol of trialdehyde pyrogallol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of triaminoguanidine hydrochloride (Dt) and 10 mmol of sodium sulfate (strong acid and strong base salt, Figure 11 (a) without sodium sulfate, Figure 11 (b) with sodium sulfate) were added to 40 mL of deionized water, and an aqueous phase mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous phase solution was slowly added to the aqueous phase solution along the periphery of the culture dish. The film formation conditions at different times were observed, and the comparison showed that the addition of sodium sulfate could accelerate the film formation of the TpDt cationic covalent organic framework polymer.
测试Pa-SO3H单体的传质速率,在培养皿中下层加入1 mL DCM纯溶剂,在上层中加入3 mL含有或者不含有Na2SO4的水溶液,利用紫外分光光度计测试传质速率,图12中(a)、(b)图展现出在强酸强碱盐(强酸强碱盐)的存在下展现出快速的传质速率(k=0.06075 A/min),使得快速成膜,图9中(c)图缺乏强酸强碱盐(强酸强碱盐)展现出缓慢的传质速率(k=0.01075 A/min),导致缓慢成膜或者不成膜(表1)。To test the mass transfer rate of Pa-SO 3 H monomer, 1 mL of pure DCM solvent was added to the lower layer of the culture dish, and 3 mL of aqueous solution containing or not containing Na 2 SO 4 was added to the upper layer. The mass transfer rate was tested using a UV spectrophotometer. Figures 12 (a) and (b) show that in the presence of strong acid and strong base salts (strong acid and strong base salts), a fast mass transfer rate (k = 0.06075 A/min) was exhibited, resulting in rapid film formation. Figure 9 (c) shows a slow mass transfer rate (k = 0.01075 A/min) in the absence of strong acid and strong base salts (strong acid and strong base salts), resulting in slow film formation or no film formation (Table 1).
综上所述,本发明通过无机盐提供的加速单体传质和界面预组装策略聚合法能提供一种快速制备阳离子、阴离子和中性共价有机高分子膜的方法。该方法有一定的普适性,制备出来的COFs膜具有成膜性好,高结晶度的特点。其中TpPa-SO3H阴离子型共价有机框架膜的具有十分优异的分子分离能力。In summary, the present invention provides a method for rapidly preparing cationic, anionic and neutral covalent organic polymer membranes by accelerating monomer mass transfer and interfacial preassembly strategy polymerization provided by inorganic salts. The method has certain universality, and the prepared COFs membrane has the characteristics of good film-forming property and high crystallinity. Among them, the TpPa-SO 3 H anionic covalent organic framework membrane has very excellent molecular separation ability.
对比例1:无强酸强碱盐添加时尝试制备TpDa-SO3H阴离子共价有机框架膜。Comparative Example 1: Attempt to prepare TpDa-SO 3 H anionic covalent organic framework membrane without adding strong acid or strong base salt.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2,4-二氨基苯磺酸(Da-SO3H)加入到40 mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中,将培养皿静置在室温条件下48 h无法得到薄膜。在这种无强酸强碱盐添加时无法得到膜。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 2,4-diaminobenzenesulfonic acid (Da-SO 3 H) was added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was left at room temperature for 48 h, but no film was obtained. In this case, no film could be obtained without the addition of strong acid or strong base salt.
对比例2:无强酸强碱盐添加时尝试制备TpPa-SO3H阴离子共价有机框架膜。Comparative Example 2: An attempt was made to prepare a TpPa-SO 3 H anionic covalent organic framework membrane without adding strong acid or strong base salt.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2,5-二氨基苯磺酸(Pa-SO3H)加入到40 mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中,将培养皿静置在室温条件下1 h无膜。在这种无强酸强碱盐添加时无法得到膜,随着反应时间为4 h时,得到膜,但是这种膜非常容易碎,不能够用于分离。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 2,5-diaminobenzenesulfonic acid (Pa-SO 3 H) was added to 40 mL of deionized water, and an aqueous phase mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous phase mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was left to stand at room temperature for 1 h without a film. In this case, no film could be obtained without the addition of strong acid or strong base salt. When the reaction time was 4 h, a film was obtained, but this film was very fragile and could not be used for separation.
对比例3:无强酸强碱盐添加时尝试制备TpBa-SO3H阴离子共价有机框架膜。Comparative Example 3: An attempt was made to prepare a TpBa-SO 3 H anionic covalent organic framework membrane without adding strong acid or strong base salt.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的4,4'-二氨基联苯-2,2'-二磺酸(Ba-SO3H)加入到40mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中,将培养皿静置在室温条件下3个月无膜。在这种无强酸强碱盐添加时无法得到膜。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonication; 3 mmol of 4,4'-diaminobiphenyl-2,2'-disulfonic acid (Ba-SO 3 H) was added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonication. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was left at room temperature for 3 months without a film. No film could be obtained when no strong acid or strong base salt was added.
对比例4:添加弱酸强碱盐(如:碳酸氢钠、磷酸钠等)时尝试制备TpPa-SO3H阴离子共价有机框架膜。Comparative Example 4: When weak acid and strong base salts (such as sodium bicarbonate, sodium phosphate, etc.) are added, an attempt is made to prepare a TpPa-SO 3 H anionic covalent organic framework membrane.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2 ,5-二氨基苯磺酸(Pa-SO3H)和10 mmol弱酸强碱盐(如:碳酸氢钠,磷酸钠等其中任一种)加入到40 mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80 mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中,将培养皿静置在室温条件下30天无膜。在这种弱酸强碱盐添加时无法得到膜。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonication. 3 mmol of 2,5-diaminobenzenesulfonic acid (Pa-SO 3 H) and 10 mmol of weak acid and strong base salt (such as sodium bicarbonate, sodium phosphate, etc.) were added to 40 mL of deionized water, and an aqueous phase mixed solution was obtained by ultrasonication. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous phase mixed solution was slowly added to the organic phase solution along the periphery of the culture dish. The culture dish was left at room temperature for 30 days without a film. No film was obtained when this weak acid and strong base salt was added.
对比例5:添加不同金属阳离子硫酸盐(如:硫酸镁,硫酸铁等)时尝试制备TpPa-SO3H阴离子共价有机框架膜。Comparative Example 5: When adding different metal cation sulfates (such as magnesium sulfate, iron sulfate, etc.), an attempt was made to prepare a TpPa-SO 3 H anion covalent organic framework membrane.
将2 mmol三醛基间苯三酚加入到二氯甲烷有机相溶液中,超声得到澄清溶液;将3mmol的2,5-二氨基苯磺酸(Pa-SO3H)和10 mmol硫酸镁或者硫酸铁等其中任一种加入到40mL去离子水中,超声得到水相混合溶液。将二氯甲烷溶液加入到80mL培养皿中,然后将水相混合溶液沿培养皿周围缓慢加入到有机相溶液中,将培养皿静置在室温条件下5天。在这种情况下无法得到TpPa-SO3H阴离子共价有机框架膜。2 mmol of trialdehyde phloroglucinol was added to the dichloromethane organic phase solution, and a clear solution was obtained by ultrasonic treatment. 3 mmol of 2,5-diaminobenzenesulfonic acid (Pa-SO 3 H) and 10 mmol of magnesium sulfate or ferric sulfate were added to 40 mL of deionized water, and an aqueous mixed solution was obtained by ultrasonic treatment. The dichloromethane solution was added to an 80 mL culture dish, and then the aqueous mixed solution was slowly added to the organic phase solution along the periphery of the culture dish, and the culture dish was left to stand at room temperature for 5 days. In this case, the TpPa-SO 3 H anionic covalent organic framework membrane could not be obtained.
前述对本发明的具体示例性实施方案的描述是为了说明和例证的目的。这些描述并非想将本发明限定为所公开的精确形式,并且很显然,根据上述教导,可以进行很多改变和变化。对示例性实施例进行选择和描述的目的在于解释本发明的特定原理及其实际应用,从而使得本领域的技术人员能够实现并利用本发明的各种不同的示例性实施方案以及各种不同的选择和改变。本发明的范围意在由权利要求书及其等同形式所限定。The foregoing description of specific exemplary embodiments of the present invention is for the purpose of illustration and demonstration. These descriptions are not intended to limit the present invention to the precise form disclosed, and it is clear that many changes and variations can be made based on the above teachings. The purpose of selecting and describing the exemplary embodiments is to explain the specific principles of the present invention and its practical application, so that those skilled in the art can realize and utilize various different exemplary embodiments of the present invention and various different selections and changes. The scope of the present invention is intended to be limited by the claims and their equivalents.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410359809.7A CN117946355B (en) | 2024-03-27 | 2024-03-27 | Preparation method and application of asymmetric self-supporting covalent organic framework film |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410359809.7A CN117946355B (en) | 2024-03-27 | 2024-03-27 | Preparation method and application of asymmetric self-supporting covalent organic framework film |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117946355A true CN117946355A (en) | 2024-04-30 |
CN117946355B CN117946355B (en) | 2024-06-18 |
Family
ID=90794949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410359809.7A Active CN117946355B (en) | 2024-03-27 | 2024-03-27 | Preparation method and application of asymmetric self-supporting covalent organic framework film |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117946355B (en) |
Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040024131A1 (en) * | 2000-11-14 | 2004-02-05 | Frank Borner | Melt-processable amino resin based on 1,3,5-triazines and aldehydes |
CN110605098A (en) * | 2019-09-30 | 2019-12-24 | 江南大学 | A non-reversible covalent organic framework for efficient and selective recovery of gold and its preparation method |
CN111647184A (en) * | 2020-06-28 | 2020-09-11 | 闽江学院 | Covalent organic framework film material for removing triclosan in environmental water and preparation method and application thereof |
CN111871381A (en) * | 2020-07-10 | 2020-11-03 | 福州大学 | Magnetic covalent organic framework adsorbent and method for separating and purifying plasmid DNA by using same |
CN111921559A (en) * | 2020-08-16 | 2020-11-13 | 复旦大学 | Single-site transition metal covalent organic framework photocatalyst and preparation method thereof |
CN112321782A (en) * | 2020-10-19 | 2021-02-05 | 华中科技大学 | Crystalline covalent triazine organic framework material and preparation method and application thereof |
CN112321839A (en) * | 2020-10-30 | 2021-02-05 | 郑州轻工业大学 | Bimetal covalent organic framework material, preparation method thereof and aptamer sensor |
CN112679731A (en) * | 2020-12-21 | 2021-04-20 | 同济大学 | Covalent organic framework material containing sulfonic acid group and preparation and application thereof |
CN113061333A (en) * | 2020-01-02 | 2021-07-02 | 万华化学集团股份有限公司 | Low-dielectric thermoplastic polyurethane composite material and preparation method and application thereof |
CN113372523A (en) * | 2021-04-02 | 2021-09-10 | 同济大学 | Transition metal ion modified sulfonic acid covalent organic framework material and preparation and application thereof |
CN113621118A (en) * | 2021-07-08 | 2021-11-09 | 南京理工大学 | Alkyl chain modified covalent organic framework membrane, preparation method and application thereof |
CN113788944A (en) * | 2021-09-23 | 2021-12-14 | 福州大学 | Porous organic polymer and preparation method and application thereof |
WO2022061666A1 (en) * | 2020-09-24 | 2022-03-31 | 浙江大学 | Method for preparing hollow covalent organic framework material |
CN114456338A (en) * | 2021-12-24 | 2022-05-10 | 江南大学 | Photocatalytic synthesis method of benzimidazolyl covalent organic framework material |
CN114456339A (en) * | 2022-02-11 | 2022-05-10 | 天津大学浙江研究院 | Covalent organic framework film with high content of ionic groups, preparation method and application thereof |
CN115178109A (en) * | 2022-08-01 | 2022-10-14 | 同济大学 | Composite nanofiltration membrane based on covalent organic framework compound NCOF and preparation method thereof |
WO2022252484A1 (en) * | 2021-06-01 | 2022-12-08 | 浙江大学 | Polymer self-supporting nanofilm, continuous and macro-scale preparation method therefor and application thereof |
CN115814601A (en) * | 2022-10-31 | 2023-03-21 | 浙江大学 | Preparation method and application of ionic covalent organic framework membrane material |
CN115850625A (en) * | 2022-11-04 | 2023-03-28 | 南京工业大学 | Preparation method of a covalent organic framework and its application in photocatalytic seawater hydrogen evolution |
CN115947911A (en) * | 2023-02-28 | 2023-04-11 | 天津大学 | Diketimine-linked covalent organic framework high polymer material and preparation method thereof |
WO2024015937A2 (en) * | 2022-07-13 | 2024-01-18 | Northwestern University | Covalent organic frameworks for gas chromatographic separations |
CN117482758A (en) * | 2023-10-30 | 2024-02-02 | 东北林业大学 | An ionic covalent organic framework composite membrane, its preparation method and its application in separating dyes and salts |
-
2024
- 2024-03-27 CN CN202410359809.7A patent/CN117946355B/en active Active
Patent Citations (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040024131A1 (en) * | 2000-11-14 | 2004-02-05 | Frank Borner | Melt-processable amino resin based on 1,3,5-triazines and aldehydes |
CN110605098A (en) * | 2019-09-30 | 2019-12-24 | 江南大学 | A non-reversible covalent organic framework for efficient and selective recovery of gold and its preparation method |
CN113061333A (en) * | 2020-01-02 | 2021-07-02 | 万华化学集团股份有限公司 | Low-dielectric thermoplastic polyurethane composite material and preparation method and application thereof |
CN111647184A (en) * | 2020-06-28 | 2020-09-11 | 闽江学院 | Covalent organic framework film material for removing triclosan in environmental water and preparation method and application thereof |
CN111871381A (en) * | 2020-07-10 | 2020-11-03 | 福州大学 | Magnetic covalent organic framework adsorbent and method for separating and purifying plasmid DNA by using same |
CN111921559A (en) * | 2020-08-16 | 2020-11-13 | 复旦大学 | Single-site transition metal covalent organic framework photocatalyst and preparation method thereof |
WO2022061666A1 (en) * | 2020-09-24 | 2022-03-31 | 浙江大学 | Method for preparing hollow covalent organic framework material |
CN112321782A (en) * | 2020-10-19 | 2021-02-05 | 华中科技大学 | Crystalline covalent triazine organic framework material and preparation method and application thereof |
CN112321839A (en) * | 2020-10-30 | 2021-02-05 | 郑州轻工业大学 | Bimetal covalent organic framework material, preparation method thereof and aptamer sensor |
CN112679731A (en) * | 2020-12-21 | 2021-04-20 | 同济大学 | Covalent organic framework material containing sulfonic acid group and preparation and application thereof |
CN113372523A (en) * | 2021-04-02 | 2021-09-10 | 同济大学 | Transition metal ion modified sulfonic acid covalent organic framework material and preparation and application thereof |
WO2022252484A1 (en) * | 2021-06-01 | 2022-12-08 | 浙江大学 | Polymer self-supporting nanofilm, continuous and macro-scale preparation method therefor and application thereof |
CN113621118A (en) * | 2021-07-08 | 2021-11-09 | 南京理工大学 | Alkyl chain modified covalent organic framework membrane, preparation method and application thereof |
CN113788944A (en) * | 2021-09-23 | 2021-12-14 | 福州大学 | Porous organic polymer and preparation method and application thereof |
CN114456338A (en) * | 2021-12-24 | 2022-05-10 | 江南大学 | Photocatalytic synthesis method of benzimidazolyl covalent organic framework material |
CN114456339A (en) * | 2022-02-11 | 2022-05-10 | 天津大学浙江研究院 | Covalent organic framework film with high content of ionic groups, preparation method and application thereof |
WO2024015937A2 (en) * | 2022-07-13 | 2024-01-18 | Northwestern University | Covalent organic frameworks for gas chromatographic separations |
CN115178109A (en) * | 2022-08-01 | 2022-10-14 | 同济大学 | Composite nanofiltration membrane based on covalent organic framework compound NCOF and preparation method thereof |
CN115814601A (en) * | 2022-10-31 | 2023-03-21 | 浙江大学 | Preparation method and application of ionic covalent organic framework membrane material |
CN115850625A (en) * | 2022-11-04 | 2023-03-28 | 南京工业大学 | Preparation method of a covalent organic framework and its application in photocatalytic seawater hydrogen evolution |
CN115947911A (en) * | 2023-02-28 | 2023-04-11 | 天津大学 | Diketimine-linked covalent organic framework high polymer material and preparation method thereof |
CN117482758A (en) * | 2023-10-30 | 2024-02-02 | 东北林业大学 | An ionic covalent organic framework composite membrane, its preparation method and its application in separating dyes and salts |
Non-Patent Citations (2)
Title |
---|
ZHU T, ET AL: "Recent Progress in Atmospheric Chemistry Research in China: Establishing a Theoretical Framework for the Air Pollution Complex", ADVANCES IN ATMOSPHERIC SCIENCES, vol. 40, 31 August 2023 (2023-08-31), pages 1339 - 1361 * |
谢海英;陈可先;姚加;李浩然;: "N-羟基邻苯二甲酰亚胺类羟胺有机催化剂在分子氧氧化研究中的支载策略", 化学研究, no. 02, 31 March 2016 (2016-03-31), pages 135 - 143 * |
Also Published As
Publication number | Publication date |
---|---|
CN117946355B (en) | 2024-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Liu et al. | Self-healing hyper-cross-linked metal–organic polyhedra (HCMOPs) membranes with antimicrobial activity and highly selective separation properties | |
Gole et al. | Microtubular self‐assembly of covalent organic frameworks | |
Kang et al. | Scalable crystalline porous membranes: current state and perspectives | |
Cai et al. | The organic flatland—recent advances in synthetic 2D organic layers | |
CN106139934B (en) | Preparation method of triptycene-based polymer separation membrane | |
CN103272491B (en) | Preparation method for in situ self-assembled organic/inorganic hybrid membrane based on coordination | |
CN104804198B (en) | The two-dimension single layer supermolecule polymer of self-supporting and its application in terms of nanometer seperation film | |
CN111282405A (en) | Modified metal organic framework nanosheet and preparation method thereof | |
US9212238B2 (en) | Microparticle, addition agent and filtering membrane | |
CN113908703B (en) | A charged nanofiltration membrane based on polymer nanoparticles and its preparation method | |
Hu et al. | Self‐assembled polymeric materials: design, morphology, and functional‐oriented applications | |
CN117946355B (en) | Preparation method and application of asymmetric self-supporting covalent organic framework film | |
CN102806071A (en) | Material for hollow nano organosilicon sphere and preparation method of material | |
CN108373540B (en) | A kind of preparation method of fluorine-containing amphiphilic polyacrylic block copolymer micelle, obtained product and application | |
Li et al. | Progress in Isocyanide‐Based Step‐Growth Polymerization | |
CN110204749B (en) | Porous membrane based on aminated copolymerized microspheres and polyaldehyde and preparation method thereof | |
CN114292373A (en) | A method for glycerol-regulated liquid phase synthesis of covalent organic framework nanosheets | |
Huang et al. | Thin film composite polyamide nanofiltration membranes with interlayer constructed with core-shell structured polystyrene-polyacrylamide nanospheres for antibiotics separation | |
CN102627783B (en) | Crosslinked polyethylene pyrrolidone-base fluorescent composite thin film and preparation method thereof | |
Zhang et al. | Synthesis methods of organic two‐dimensional materials | |
CN114605617B (en) | Preparation method and application of two-dimensional phenyl framework porous material | |
Xu et al. | Coacervate‐Assisted Polymerization‐Induced Self‐Assembly of Chiral Alternating Copolymers into Hierarchical Bishell Capsules with Sub‐5 nm Ultrathin Lamellae | |
CN115920668A (en) | Self-supporting COFs membrane, preparation method and application based on DES-H2O interfacial polymerization method | |
CN118742595A (en) | Bipolar membrane | |
CN113717361B (en) | A method for preparing polyester film by gas phase polymerization, polyester film and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |